Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05390580 · ClinicalTrials.gov registry record · NA
Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05390580 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 40 participants.
The verdict
NCT05390580, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a randomized open-label, with blinded outcome pilot study to evaluate the effect on inflammatory laboratory values and explore clinical outcomes in patients who present with ischemic strokes due to large vessel occlusions and are treated with either current accepted management, or accepted management in addition to transcutaneous auricular vagal nerve stimulation.
Interventions
- DEVICE transcutaneous auricular vagal nerve stimulation
- DEVICE Sham transcutaneous vagal nerve stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-09-26 |
| Est. Completion | 2024-08-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05390580
The ClinicalTrials.gov registry entry for NCT05390580 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which transcutaneous auricular vagal nerve stimulation is the first listed.
NCT05390580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05390580 about?
NCT05390580 is a clinical study titled "Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct". This is a randomized open-label, with blinded outcome pilot study to evaluate the effect on inflammatory laboratory values and explore clinical outcomes in patients who present with ischemic strokes due to large vessel occlusions and are treated with either current accepted management, or accepted m...
What is the current status of trial NCT05390580?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-09-26. Estimated completion is 2024-08-23.
What interventions are being tested in trial NCT05390580?
The interventions under investigation include: transcutaneous auricular vagal nerve stimulation (DEVICE), Sham transcutaneous vagal nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT05390580?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.